A Phase 2 study of Varenicline and Guanfacine for Smoking Cessation
Completed Phase 2 NCT04198116
Study Description
Evaluating a Combination Therapy for Smoking Cessation
Study Details
- Registry ID:
- NCT04198116
- Conditions:
- Smoking Cessation
- Phase:
- Phase 2
- Target Enrollment:
- 167 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Yale University
New Haven, Connecticut, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.